Adaptimmune Therapeutics ADAPY
OTC ADAPY
$0.02 +0.00 (+0.00%)
At close: Nov 10, 2026 · 4:00 PM EST

Adaptimmune Therapeutics (ADAPY) EBT (2014 - 2025)

Updated

Adaptimmune Therapeutics' EBT was -$29.73 million in Q2 2025, compared with $70.05 million a year earlier.

Analysis

Adaptimmune Therapeutics (ADAPY) EBT (2014 - 2025) Analysis & Trends

On a trailing twelve-month basis, Adaptimmune Therapeutics' EBT was -$166.05 million through Jun 30, 2025; for FY2024, it was -$67.24 million.

  • In earlier years, EBT was -$112.54 million in FY2023, -$162.96 million in FY2022, -$157.3 million in FY2021 and -$129.93 million in FY2020.
  • Quarterly EBT has moved between -$72.52 million (Q4 2024) and $70.05 million (Q2 2024) over five years.
  • Per Business Quant data, ADAPY's EBT in the three quarters before Q2 2025 was -$47.01 million (Q1 2025), -$72.52 million (Q4 2024) and -$16.79 million (Q3 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -29.73 Mn
Mar 31, 2025 -47.01 Mn
Dec 31, 2024 -72.52 Mn
Sep 30, 2024 -16.79 Mn
Jun 30, 2024 70.05 Mn
Mar 31, 2024 -47.98 Mn
Dec 31, 2023 -48.57 Mn
Sep 30, 2023 -44.91 Mn
Jun 30, 2023 -20.71 Mn
Mar 31, 2023 1.66 Mn
Dec 31, 2022 -28.26 Mn
Sep 30, 2022 -41.02 Mn
Jun 30, 2022 -44.05 Mn
Mar 31, 2022 -49.63 Mn
Dec 31, 2021 -38.65 Mn
Sep 30, 2021 -42.19 Mn
Jun 30, 2021 -38.99 Mn
Mar 31, 2021 -37.47 Mn
Dec 31, 2020 -36.56 Mn
Sep 30, 2020 -35.42 Mn
API Access

Adaptimmune Therapeutics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ADAPY&period=max&api_key=YOUR_API_KEY